Radiology -Imaging pediatric liver lesions , classification age wise distribution , all pathognomic imaging features any syndrome association tumour markers levels and it's associated ,hepatoblastoma and it's type , image ,infentile hemngioendothelioma,mesenchymal hamartoma ,HCC ,their close dd and how to diffanciate ,fibrolamilar carcinoma,fnh, hepatocellular adenoma, undifferentiate embryonal sarcoma, mesenchymal hamartoma ,epithelioid hemngioendothelioma,angisarcoma,embryonal rebdosarcoma all classic sign and pathognomic features, list of hepatic lesion to tends to rupture, different modalities xray ct MRI features, liver protocol ct and MRI , functional imaging findings also to be included
pediatric liver lesions imaging classification age radiology CT MRI features hepatoblastoma infantile hemangioma undifferentiated embryonal sarcoma
pediatric liver lesions classification age imaging CT MRI features hepatoblastoma hemangioma mesenchymal hamartoma undifferentiated embryonal sarcoma rhabdomyosarcoma
liver lesion rupture risk hepatocellular adenoma HCC hepatoblastoma angiosarcoma liver protocol CT MRI functional imaging DWI hepatobiliary
What's Covered
-
Age-Based Classification Table - Master table mapping every lesion to its peak age group (0-6 months through adolescence)
-
Tumor Markers & Syndrome Associations - AFP levels for every lesion; Beckwith-Wiedemann/FAP (hepatoblastoma), OCP/GSD (adenoma), HHT (FNH), Vinyl chloride/Thorotrast (angiosarcoma), etc.
-
Individual Lesion Profiles (12 lesions with full imaging for every modality):
- Hepatoblastoma (PRETEXT staging, 4 histologic subtypes)
- Infantile hemangioendothelioma (Type 1 vs RICH vs NICH)
- Mesenchymal hamartoma
- HCC + LIRADS criteria
- Fibrolamellar vs FNH comparison table (T2-dark vs T2-bright scar; HBP behavior)
- FNH (spoke-wheel, HBP hyperintensity)
- Hepatocellular adenoma (all 4 molecular subtypes: HNF1A, beta-catenin, inflammatory, unclassified)
- Undifferentiated embryonal sarcoma (CT-MRI discordance = pathognomonic)
- Epithelioid hemangioendothelioma (lollipop sign, capsular retraction)
- Angiosarcoma (Thorotrast sign, aggressive growth)
- Embryonal rhabdomyosarcoma (biliary, botryoid, MRCP filling defects)
-
DD Table - Cystic vs solid vs mixed; AFP-based approach
-
Lesions Prone to Rupture - Ranked list with CT sentinel clot sign
-
Multimodality Features - X-ray, US/Doppler, CT liver protocol (phases + parameters), MRI liver protocol (full sequence table), hepatobiliary phase interpretation per lesion
-
Functional Imaging - DWI/ADC values, CEUS patterns, PET-CT, nuclear medicine (Tc-99m RBC for hemangioma)
-
Master Classic Signs Table - 20 pathognomonic signs organized by modality
Radiology -Imaging begin pediatric liver lesions , infantile hemangioendothelioma, pathognomic feature , imaging sign and feature , hepatic vascular malformations and it's types ,mesenchymal hamartoma,fnh ,hepatic adenoma , imaging features association, Radiological aspect of treatment,dd , regenerative nodules
infantile hemangioendothelioma hepatic imaging pathognomonic features types RICH NICH GLUT1 treatment radiology embolization propranolol 2023 2024
hepatic vascular malformations types congenital portosystemic shunt arterioportal fistula peliosis hepatis imaging radiology classification
hepatic vascular malformations classification types imaging radiology pediatric portosystemic shunt arterioportal fistula Abernethy
FNH hepatocellular adenoma treatment embolization ablation resection imaging follow-up radiology 2023 2024 guidelines
What's Included
Section 1 - Infantile Hemangioendothelioma / Infantile Hepatic Hemangioma (IHH)
- Full classification table: IHH vs RICH vs NICH vs PICH with GLUT1 status
- GLUT1 positivity = pathognomonic for true IHH (differentiates from all vascular malformations)
- Systematic imaging per modality: plain film, USS/Doppler, CT, MRI - with all classic signs
- Pathognomonic features: centripetal fill-in, T2 "light-bulb," high-flow low-resistance Doppler, no perilesional edema
- RICH-specific features: thick rim enhancement, vascular aneurysms, calcification
- Treatment radiology: propranolol response monitoring on serial USS; TAE technique + pre/post-procedural imaging; post-embolization MRI findings; follow-up schedule
- Complete DD table
Section 2 - Hepatic Vascular Malformations
- Full classification: arterioportal fistulae, congenital portosystemic shunts (Abernethy Types I-IV), AVMs, portal malformations, veno-occlusive disease, HHT, peliosis hepatis
- Abernethy malformation imaging and nodule surveillance
- "Arterialization sign" on Doppler for AP fistulae
Section 3 - Mesenchymal Hamartoma
- "Swiss-cheese"/"bunch of grapes" T2W appearance
- Normal AFP as key differentiator
- No calcification (unlike hepatoblastoma)
- Treatment radiology: MRI pre-op planning, MRCP for biliary non-communication, post-surgical surveillance
Section 4 - FNH
- Spoke-wheel Doppler; homogeneous arterial enhancement; T2-bright scar; HBP isointensity/hyperintensity = most specific sign
- CEUS spoke-wheel centrifugal pattern for < 3 cm lesions
- Treatment: none needed if diagnosis confirmed on Gd-EOB-DTPA MRI
- Full DD vs adenoma, fibrolamellar, HCC, hemangioma
Section 5 - Hepatocellular Adenoma
- Full WHO 2019 molecular subtype table: HNF1A (signal dropout), Inflammatory (atoll sign), Beta-catenin (HBP paradoxically iso/hyperintense = highest HCC risk)
- In-phase/out-of-phase T1W for fat (HNF1A) subtyping
- ACG 2024 + EASL treatment guidelines with imaging decision points: embolization for acute bleed, resection criteria, ablation post-procedure MRI response criteria
Section 6 - Regenerative Nodules
- Full spectrum: RN → siderotic → steatotic → LGDN → HGDN → early HCC
- MRI characterization table: T1, T2, enhancement, HBP per nodule type
- "Nodule-within-a-nodule" sign for HGDN with early HCC
- Siderotic nodule: dark on ALL sequences = blooming artifact on GRE
- LIRADS-based surveillance integration